FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
With mAb aggregate often at very low levels (<0.1 % by peak area compared to monomer) and fragment separation a requirement, adequate resolution and peak shape have become even more crucial to method outcomes. To address this need, the robust set of Biozen SEC columns were developed with a combination of UHPLC efficiency and higher sensitivity, to drive resolution and identification of even lower level targets.
With mAb aggregate often at very low levels (<0.1 % by peak area compared to monomer) and fragment separation a requirement, adequate resolution and peak shape have become even more crucial to method outcomes. To address this need, the robust set of Biozen SEC columns were developed with a combination of UHPLC efficiency and higher sensitivity, to drive resolution and identification of even lower level targets.
With mAb aggregate often at very low levels (<0.1 % by peak area compared to monomer) and fragment separation a requirement, adequate resolution and peak shape have become even more crucial to method outcomes. To address this need, the robust set of Biozen SEC columns were developed with a combination of UHPLC efficiency and higher sensitivity, to drive resolution and identification of even lower level targets.